Cargando…
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
In this article, the third in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues review how prognostic models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564751/ https://www.ncbi.nlm.nih.gov/pubmed/23393430 http://dx.doi.org/10.1371/journal.pmed.1001381 |
_version_ | 1782258346849468416 |
---|---|
author | Steyerberg, Ewout W. Moons, Karel G. M. van der Windt, Danielle A. Hayden, Jill A. Perel, Pablo Schroter, Sara Riley, Richard D. Hemingway, Harry Altman, Douglas G. |
author_facet | Steyerberg, Ewout W. Moons, Karel G. M. van der Windt, Danielle A. Hayden, Jill A. Perel, Pablo Schroter, Sara Riley, Richard D. Hemingway, Harry Altman, Douglas G. |
author_sort | Steyerberg, Ewout W. |
collection | PubMed |
description | In this article, the third in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues review how prognostic models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples. |
format | Online Article Text |
id | pubmed-3564751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35647512013-02-07 Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research Steyerberg, Ewout W. Moons, Karel G. M. van der Windt, Danielle A. Hayden, Jill A. Perel, Pablo Schroter, Sara Riley, Richard D. Hemingway, Harry Altman, Douglas G. PLoS Med Guidelines and Guidance In this article, the third in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues review how prognostic models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples. Public Library of Science 2013-02-05 /pmc/articles/PMC3564751/ /pubmed/23393430 http://dx.doi.org/10.1371/journal.pmed.1001381 Text en © 2013 Steyerberg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Guidelines and Guidance Steyerberg, Ewout W. Moons, Karel G. M. van der Windt, Danielle A. Hayden, Jill A. Perel, Pablo Schroter, Sara Riley, Richard D. Hemingway, Harry Altman, Douglas G. Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title_full | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title_fullStr | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title_full_unstemmed | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title_short | Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research |
title_sort | prognosis research strategy (progress) 3: prognostic model research |
topic | Guidelines and Guidance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564751/ https://www.ncbi.nlm.nih.gov/pubmed/23393430 http://dx.doi.org/10.1371/journal.pmed.1001381 |
work_keys_str_mv | AT steyerbergewoutw prognosisresearchstrategyprogress3prognosticmodelresearch AT moonskarelgm prognosisresearchstrategyprogress3prognosticmodelresearch AT vanderwindtdaniellea prognosisresearchstrategyprogress3prognosticmodelresearch AT haydenjilla prognosisresearchstrategyprogress3prognosticmodelresearch AT perelpablo prognosisresearchstrategyprogress3prognosticmodelresearch AT schrotersara prognosisresearchstrategyprogress3prognosticmodelresearch AT rileyrichardd prognosisresearchstrategyprogress3prognosticmodelresearch AT hemingwayharry prognosisresearchstrategyprogress3prognosticmodelresearch AT altmandouglasg prognosisresearchstrategyprogress3prognosticmodelresearch AT prognosisresearchstrategyprogress3prognosticmodelresearch |